Thomas P Miller

  • 19247 Citations
  • 57 h-Index
1978 …2016

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2003

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

Rosenwald, A., Wright, G., Wiestner, A., Chan, W. C., Connors, J. M., Campo, E., Gascoyne, R. D., Grogan, T. M., Muller-Hermelink, H. K., Smeland, E. B., Chiorazzi, M., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Henrickson, S., Yang, L., Powell, J., Wilson, W. H., Jaffe, E. S. & 19 others, Simon, R., Klausner, R. D., Montserrat, E., Bosch, F., Greiner, T. C., Weisenburger, D. D., Sanger, W. G., Dave, B. J., Lynch, J. C., Vose, J., Armitage, J. O., Fisher, R. I., Miller, T. P., LeBlanc, M., Ott, G., Kvaloy, S., Holte, H., Delabie, J. & Staudt, L. M., Feb 2003, In : Cancer Cell. 3, 2, p. 185-197 13 p.

Research output: Contribution to journalArticle

692 Scopus citations
2002

External beam radiation therapy in the treatment of patients with extranodal stage IA non-Hodgkin's lymphoma

Briggs, J. H., Algan, Ö., Miller, T. P. & Oleson, J. R., Feb 18 2002, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 25, 1, p. 34-37 4 p.

Research output: Contribution to journalArticle

7 Scopus citations

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Konrad Muller-Hermelink, H., Smeland, E. B., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Yang, L., Wilson, W. H., Jaffe, E. S., Simon, R., Klausner, R. D., Powell, J., Duffey, P. L. & 20 others, Longo, D. L., Greiner, T. C., Weisenburger, D. D., Sanger, W. G., Dave, B. J., Lynch, J. C., Vose, J., Armitage, J. O., Montserrat, E., López-Guillermo, A., Grogan, T. M., Miller, T. P., Leblanc, M., Ott, G., Kvaloy, S., Delabie, J., Holte, H., Krajci, P., Stokke, T. & Staudt, L. M., Jun 20 2002, In : New England Journal of Medicine. 346, 25, p. 1937-1947 11 p.

Research output: Contribution to journalArticle

2774 Scopus citations
2001

Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: A Southwest Oncology Group Study

Gaynor, E. R., Unger, J. M., Miller, T. P., Grogan, T. M., White, J., Mills, G. M., Balcerzak, S. P., Varterasian, M., LeBlanc, M. & Fisher, R. I., Feb 1 2001, In : Journal of Clinical Oncology. 19, 3, p. 750-755 6 p.

Research output: Contribution to journalArticle

27 Scopus citations

Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease

Press, O. W., LeBlanc, M., Lichter, A. S., Grogan, T. M., Unger, J. M., Wasserman, T. H., Gaynor, E. R., Peterson, B. A., Miller, T. P. & Fisher, R. I., Nov 15 2001, In : Journal of Clinical Oncology. 19, 22, p. 4238-4244 7 p.

Research output: Contribution to journalArticle

118 Scopus citations

The Burkitt-like lymphomas: A Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

Braziel, R. M., Arber, D. A., Slovak, M. L., Gulley, M. L., Spier, C., Kjeldsberg, C., Unger, J., Miller, T. P., Tubbs, R., Leith, C., Fisher, R. I. & Grogan, T. M., Jun 15 2001, In : Blood. 97, 12, p. 3713-3720 8 p.

Research output: Contribution to journalArticle

89 Scopus citations
2000

Interferon alfa consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non- Hodgkin's lymphoma: Results of the Southwest Oncology Group randomized phase III study 8809

Fisher, R. I., Dana, B. W., LeBlanc, M., Kjeldsberg, C., Forman, J. D., Unger, J. M., Balcerzak, S. P., Gaynor, E. R., Roy, V. & Miller, T., May 2000, In : Journal of Clinical Oncology. 18, 10, p. 2010-2016 7 p.

Research output: Contribution to journalArticle

75 Scopus citations

Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma

Stopeck, A. T., Gessner, A., Miller, T. P., Hersh, E. M., Johnson, C. S., Cui, H., Frutiger, Y. & Grogan, T. M., Jan 1 2000, In : Clinical Cancer Research. 6, 10, p. 3904-3909 6 p.

Research output: Contribution to journalArticle

57 Scopus citations

Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: A Southwest oncology group trial

Taylor, C. W., LeBlanc, M., Fisher, R. I., Moore, D. F., Roach, R. W., Elias, L. & Miller, T. P., Dec 19 2000, In : Anti-cancer drugs. 11, 9, p. 695-700 6 p.

Research output: Contribution to journalArticle

18 Scopus citations
1999

Phase II trial of menogaril in non-Hodgkin's lymphomas: A southwest oncology group trial

Moore, D. F., Brown, T. D., LeBlanc, M., Dahlberg, S., Miller, T. P., McClure, S. & Fisher, R. I., Dec 22 1999, In : Investigational New Drugs. 17, 2, p. 169-172 4 p.

Research output: Contribution to journalArticle

2 Scopus citations
1998

A phase I/II trial of paclitaxel for non-Hodgkin's lymphoma followed by paclitaxel plus quinine in drug-resistant disease

Miller, T. P., Chase, E. M., Dorr, R., Dalton, W. S., Lam, K. S. & Salmon, S. E., Jan 1 1998, In : Anti-cancer drugs. 9, 2, p. 135-140 6 p.

Research output: Contribution to journalArticle

25 Scopus citations

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

Miller, T. P., Dahlberg, S., Cassady, J. R., Adelstein, D. J., Spier, C. M., Grogan, T. M., LeBlanc, M., Carlin, S., Chase, E. & Fisher, R. I., Jul 2 1998, In : New England Journal of Medicine. 339, 1, p. 21-26 6 p.

Research output: Contribution to journalArticle

803 Scopus citations

New REAL clinical entities

Fisher, R. I., Miller, T. P. & Grogan, T. M., Jul 29 1998, In : Cancer Journal from Scientific American. 4, SUPPL. 2, p. S5-S12

Research output: Contribution to journalArticle

12 Scopus citations
1997

A southwest oncology group perspective on the revised European-American lymphoma classification

Grogan, T. M., Miller, T. P., Fisher, R. I. & Graff, J. C., Jan 1 1997, In : Hematology/Oncology Clinics of North America. 11, 5, p. 819-846 28 p.

Research output: Contribution to journalArticle

11 Scopus citations

Follicular lymphomas: Do histologic subtypes predict outcome?

Miller, T. P., LeBlanc, M., Grogan, T. M., Fisher, R. I. & Graff, J. C., Jan 1 1997, In : Hematology/Oncology Clinics of North America. 11, 5, p. 893-900 8 p.

Research output: Contribution to journalArticle

43 Scopus citations
1995

A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group study

Fisher, R. I., Dahlberg, S., Nathwani, B. N., Banks, P. M., Miller, T. P. & Grogan, T. M., Jan 1 1995, In : Blood. 85, 4, p. 1075-1082 8 p.

Research output: Contribution to journalArticle

Open Access
307 Scopus citations
1994

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: Results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study

Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A. & Miller, T. P., Feb 23 1994, In : Annals of Oncology. 5, SUPPL. 2, p. 91-95 5 p.

Research output: Contribution to journalArticle

64 Scopus citations

A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma

Grever, M. R., Benedetti, J., Balcerzak, S. P., Taylor, S. A., Miller, T. P. & Dakhil, S. R., Sep 1 1994, In : Investigational New Drugs. 12, 3, p. 259-261 3 p.

Research output: Contribution to journalArticle

1 Scopus citations

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease: A Southwest Oncology Group randomized study

Fabian, C. J., Mansfield, C. M., Dahlberg, S., Jones, S. E., Miller, T. P., Van Slyck, E., Grozea, P. N., Morrison, F. S., Coltman, C. A. & Fisher, R. I., Jun 1 1994, In : Annals of internal medicine. 120, 11, p. 903-912 10 p.

Research output: Contribution to journalArticle

150 Scopus citations

Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer - A Southwest Oncology Group study

Atiba, J. O., Green, S. J., Hynes, H. E., Osborne, C. K., Miller, T. P. & Davidner, M., Jun 1 1994, In : Investigational New Drugs. 12, 2, p. 129-132 4 p.

Research output: Contribution to journalArticle

5 Scopus citations

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group trial

Miller, T. P., Grogan, T. M., Dahlberg, S., Spier, C. M., Braziel, R. M., Banks, P. M., Foucar, K., Kjeldsberg, C. R., Levy, N., Nathwani, B. N., Schnitzer, B., Tubbs, R. R., Gaynor, E. R. & Fisher, R. I., Mar 15 1994, In : Blood. 83, 6, p. 1460-1466 7 p.

Research output: Contribution to journalArticle

220 Scopus citations

The presence of bcl-l and bci-2 gene rearrangements in diffuse small cleaved-cell lymphoma

Leith, C. P., Willman, C. L., Spier, C. M., Miller, T. P. & Grogan, T. M., Sep 1994, In : Diagnostic Molecular Pathology. 3, 3, p. 178-183 6 p.

Research output: Contribution to journalArticle

2 Scopus citations
1993

Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M., Mize, E. M., Glick, J. H., Coltman, C. A. & Miller, T. P., Apr 8 1993, In : New England Journal of Medicine. 328, 14, p. 1002-1006 5 p.

Research output: Contribution to journalArticle

1892 Scopus citations

Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: Relationship to HLA expression and host immunocompetence

List, A. F., Spier, C. M., Miller, T. P. & Grogan, T. M., Mar 1993, In : Leukemia. 7, 3, p. 398-403 6 p.

Research output: Contribution to journalArticle

45 Scopus citations

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy

Dana, B. W., Dahlberg, S., Nathwani, B. N., Chase, E., Coltman, C., Miller, T. P. & Fisher, R. I., Jan 1 1993, In : Journal of Clinical Oncology. 11, 4, p. 644-651 8 p.

Research output: Contribution to journalArticle

185 Scopus citations

NCAM (CD56)-positive malignant lymphoma

Kern, W. F., Spier, C. M., Miller, T. P. & Grogan, T. M., Jan 1 1993, In : Leukemia and Lymphoma. 12, 1-2, p. 1-10 10 p.

Research output: Contribution to journalArticle

40 Scopus citations

Radiation therapy salvage of Hodgkin's disease following chemotherapy failure

Leigh, B. R., Fox, K. A., Mack, C. F., Baier, M., Miller, T. P. & Cassady, J. R., Nov 15 1993, In : International Journal of Radiation Oncology, Biology, Physics. 27, 4, p. 855-862 8 p.

Research output: Contribution to journalArticle

35 Scopus citations
1992

Diffuse small cleaved-cell lymphoma: A heterogeneous disease with distinct immunobiologic subsets

Leith, C. P., Spier, C. M., Grogan, T. M., Gonzales, G., Rangel, C. S., Rybski, J. A., Matzner, M. & Miller, T. P., Jan 1 1992, In : Journal of Clinical Oncology. 10, 8, p. 1259-1265 7 p.

Research output: Contribution to journalArticle

15 Scopus citations

Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement

Kern, W. F., Spier, C. M., Hanneman, E. H., Miller, T. P., Matzner, M. & Grogan, T. M., Jan 1 1992, In : Blood. 79, 9, p. 2432-2437 6 p.

Research output: Contribution to journalArticle

216 Scopus citations
1991

Activity of esorubicin in recurrent malignant lymphoma: A southwest oncology group study

Miller, T. P., Dahlberg, S., Salmon, S. E., Williamson, S. K., Belt, R. J., Dana, B. W. & Fisher, R. I., Jan 1 1991, In : Journal of Clinical Oncology. 9, 7, p. 1204-1209 6 p.

Research output: Contribution to journalArticle

Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: A Southwest Oncology Group study

Weick, J. K., Dahlberg, S., Fisher, R. I., Dana, B., Miller, T. P., Balcerzak, S. P. & Pierce, H. I., Jan 1 1991, In : Journal of Clinical Oncology. 9, 5, p. 748-753 6 p.

Research output: Contribution to journalArticle

36 Scopus citations

Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas

Fisher, R. I., Longo, D. L., DeVita, V. T., Hubbard, S. M., Miller, T. P. & Young, R. C., Jan 1 1991, In : Annals of Oncology. 2, SUPPL. 1, p. 33-35 3 p.

Research output: Contribution to journalArticle

Open Access
27 Scopus citations

Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease

Silver, R. T., Case, D. C., Wheeler, R. H., Miller, T. P., Stein, R. S., Stuart, J. J., Peterson, B. A., Rivkin, S. E., Golomb, H. M., Costanzi, J. J., Erslev, A. J., Reisman, A. & Dugan, M., Jan 1 1991, In : Journal of Clinical Oncology. 9, 5, p. 754-761 8 p.

Research output: Contribution to journalArticle

44 Scopus citations

Multidrug-resistant myeloma: Laboratory and clinical effects of verapamil as a chemosensitizer

Salmon, S. E., Dalton, W. S., Grogan, T. M., Plezia, P., Lehnert, M., Roe, D. J. & Miller, T. P., Jan 1 1991, In : Blood. 78, 1, p. 44-50 7 p.

Research output: Contribution to journalArticle

209 Scopus citations

Patients with localized non-Hodgkin's lymphomas provide opportunities for future research

Miller, T. P. & Grogan, T. M., Jan 1 1991, In : ONCOLOGY. 5, 8, p. 127-132 6 p.

Research output: Contribution to journalArticle

3 Scopus citations

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil

Miller, T. P., Grogan, T. M., Dalton, W. S., Spier, C. M., Scheper, R. J. & Salmon, S. E., Jan 1 1991, In : Journal of Clinical Oncology. 9, 1, p. 17-24 8 p.

Research output: Contribution to journalArticle

367 Scopus citations

Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer: A southwest oncology group study

Von Hoff, D. D., Green, S., Alberts, D. S., Stock-Novack, D. L., Surwit, E. A., Miller, T. P. & Stephens, R. L., Jan 1 1991, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 14, 3, p. 193-194 2 p.

Research output: Contribution to journalArticle

7 Scopus citations

Prediction of outcome in diffuse large cell lymphoma by the major histocompatibility complex class II (HLA-DR, DP, DQ) and class I (HLA-a, b, c) phenotype

Rybski, J. A., Spier, C. M., Miller, T. P., Lippman, S. M., Mcgee, D. L. & Grogan, T. M., Jan 1 1991, In : Leukemia and Lymphoma. 6, 1, p. 31-38 8 p.

Research output: Contribution to journalArticle

7 Scopus citations

Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration

Pennock, G. D., Dalton, W. S., Roeske, W. R., Appleton, C. P., Mosley, K., Plezia, P., Miller, T. P. & Salmon, S. E., Jan 16 1991, In : Journal of the National Cancer Institute. 83, 2, p. 105-110 6 p.

Research output: Contribution to journalArticle

160 Scopus citations
1990

Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease: A southwest oncology group study

Mansfield, C. M., Fabian, C., Jones, S., Van Slyck, E. J., Grozea, P., Morrison, F., Miller, T. P., Seibert, C. & Ayyangar, K., Dec 1 1990, In : Cancer. 66, 11, p. 2295-2299 5 p.

Research output: Contribution to journalArticle

35 Scopus citations

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma

Slymen, D. J., Miller, T. P., Lippman, S. M., Spier, C. M., Kerrigan, D. P., Rybski, J. A., Rangel, C. S., Richter, L. C. & Grogan, T. M., Jan 1 1990, In : Journal of Clinical Oncology. 8, 6, p. 986-993 8 p.

Research output: Contribution to journalArticle

47 Scopus citations

m-BACOD Treatment for intermediate- and high-grade malignant lymphomas: A Southwest Oncology Group phase II trial

Dana, B. W., Dahlberg, S., Miller, T. P., Hartsock, R. J., Balcerzak, S., Coltman, C. A., Carden, J. O., Hartley, K. & Fisher, R. I., Jan 1 1990, In : Journal of Clinical Oncology. 8, 7, p. 1155-1162 8 p.

Research output: Contribution to journalArticle

47 Scopus citations

Rationale for the use of chemotherapy in non-small cell lung cancer

Miller, T. P., Jan 1 1990, In : Seminars in Oncology. 17, 4 SUPPL. 7, p. 11-13 3 p.

Research output: Contribution to journalArticle

8 Scopus citations

Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: A Southwest Oncology Group pilot study

Taylor, C. W., Crowley, J., Williamson, S. K., Miller, T. P., Taylor, S. A., Giri, T. G. S., Stephens, R. L. & Livingston, R. B., Nov 1990, In : Journal of Clinical Oncology. 8, 11, p. 1811-1817 7 p.

Research output: Contribution to journalArticle

32 Scopus citations

Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course.

Lippman, S. M., Spier, C. M., Miller, T. P., Slymen, D. J., Rybski, J. A. & Grogan, T. M., May 1990, In : Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 3, 3, p. 361-367 7 p.

Research output: Contribution to journalArticle

48 Scopus citations

Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: A groupwide Southwest Oncology Group study

Miller, T. P., Dahlberg, S., Weick, J. K., Files, J. C., Eyre, H. J., Pendergrass, K. B. & Fisher, R. I., Dec 1990, In : Journal of Clinical Oncology. 8, 12, p. 1951-1958 8 p.

Research output: Contribution to journalArticle

49 Scopus citations
1989

Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer - A Southwest Oncology Group study

Collins, C., Higano, C. S., Livingston, R. B., Griffin, B. R., Keppen, M. D. & Miller, T. P., Aug 1 1989, In : Cancer Chemotherapy And Pharmacology. 24, 2, p. 128-132 5 p.

Research output: Contribution to journalArticle

1 Scopus citations

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: Detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy

Dalton, W. S., Grogan, T. M., Meltzer, P. S., Scheper, R. J., Durie, B. G. M., Taylor, C. W., Miller, T. P. & Salmon, S. E., Jan 1 1989, In : Journal of Clinical Oncology. 7, 4, p. 415-424 10 p.

Research output: Contribution to journalArticle

511 Scopus citations
97 Scopus citations

Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by p-glycoprotein staining

Salmon, S. E., Grogan, T. M., Miller, T., Scheper, R. & Dalton, W. S., May 3 1989, In : Journal of the National Cancer Institute. 81, 9, p. 696-701 6 p.

Research output: Contribution to journalArticle

179 Scopus citations